Remind clinical staff and others about sharps safety now that the CDC has confirmed an emergency department nurse contracted monkeypox in Florida from a needlestick.
Contaminated hands are a primary vehicle in transmitting germs and viruses, which means hand hygiene remains imperative to protect patients, staff, and visitors. According to the Centers for Disease Control and Prevention, hand hygiene is one of the most effective tools to mitigate the impact of...
Contaminated hands are a primary vehicle in transmitting germs and viruses, which means hand hygiene remains imperative to protect patients, staff, and visitors. According to the Centers for Disease Control and Prevention, hand hygiene is one of the most effective tools to mitigate the impact of...
Now that COVID-19 has reached an endemic phase, one of the biggest challenges facing healthcare organizations is keeping communities focused on containing the virus, says Janet Tomcavage, MS, executive vice president and chief nurse executive at ...
Now that COVID-19 has reached an endemic phase, one of the biggest challenges facing healthcare organizations is keeping communities focused on containing the virus, says Janet Tomcavage, MS, executive vice president and chief nurse executive at ...
If your organization has not already done so, start drawing down now from using compliance waivers granted under the COVID-19 public health emergency (PHE) declaration. On October 13, the PHE was renewed for another 90 days but it remains uncertain if it will be renewed again.
If your organization has not already done so, start drawing down now from using compliance waivers granted under the COVID-19 public health emergency (PHE) declaration. On October 13, the PHE was renewed for another 90 days but it remains uncertain if it will be renewed again.
In the first two months of the coronavirus pandemic, there were no proven therapies for COVID-19. Now, there are several therapies for COVID-19, including Paxlovid, remdesivir, and monoclonal antibodies.
In the first two months of the coronavirus pandemic, there were no proven therapies for COVID-19. Now, there are several therapies for COVID-19, including Paxlovid, remdesivir, and monoclonal antibodies.
Before COVID-19, deaths from antimicrobial resistance were headed in the right direction, decreasing by nearly 30% in hospitals between 2012 and 2017. But in 2020, resistant hospital-onset infections and deaths both increased by 15% compared to 2019.
